Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
M D Groves, V K Puduvalli, M R Gilbert, et al.
Cancer Research
|
April 23, 1999
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis
T Sano, H Lin, X Chen, et al.
Neurology
|
April 1, 1998
Correlation between dynamic MRI and outcome in patients with malignant gliomas
E T Wong, E F Jackson, K R Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials
R Said, J Banchs, J Wheler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas
V A Levin, W K A Yung, J Bruner, et al.
Gene Therapy
|
June 27, 2008
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells
T Yokoyama, E Iwado, Y Kondo, et al.
Journal of Neuro-Oncology
|
June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
J F de Groot, M R Gilbert, K Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas
F Meric, M Milas, K K Hunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Gamma-ray mutagen sensitivity and survival in patients with glioma
A J Sigurdson, M L Bondy, K R Hess, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
M D Groves, V K Puduvalli, M R Gilbert, et al.
Cancer Research
|
April 23, 1999
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis
T Sano, H Lin, X Chen, et al.
Neurology
|
April 1, 1998
Correlation between dynamic MRI and outcome in patients with malignant gliomas
E T Wong, E F Jackson, K R Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials
R Said, J Banchs, J Wheler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas
V A Levin, W K A Yung, J Bruner, et al.
Gene Therapy
|
June 27, 2008
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells
T Yokoyama, E Iwado, Y Kondo, et al.
Journal of Neuro-Oncology
|
June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
J F de Groot, M R Gilbert, K Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas
F Meric, M Milas, K K Hunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Gamma-ray mutagen sensitivity and survival in patients with glioma
A J Sigurdson, M L Bondy, K R Hess, et al.
Page
of 10